AIMS: Percutaneous left atrial appendage closure with Amplatzer(®) Cardiac Plug (St. Jude Medical Inc.) for the prevention of stroke in patients with atrial fibrillation is rapidly propagating. We sought to provide additional safety data. METHODS AND RESULTS: We have screened our database of patients having been treated with Amplatzer(®) Cardiac Plug and found 3 cases with uncommon complications that have not been reported previously. One patient experienced an embolisation of the occluder about 12 months after implantation that potentially resulted from mismatch of occluder size and landing zone. Another patient developed cardiac tamponade 9 days after implantation. This case of delayed effusion was probably not a result of interventional trauma, but might have been provoked by scratching of the inner pericardial membrane. A third patient developed a large thrombus in the left atrium which was considered to be caused by injury of the endothelial wall during implantation. The first two cases could be treated by a percutaneous procedure, the last case by cardiac surgery without any sequelae. CONCLUSIONS: Complications after left atrial appendage closure not related to a device-related thrombus can occur later after implantation. With appropriate percutaneous or surgical management these complications can be handled without sequelae.
AIMS: Percutaneous left atrial appendage closure with Amplatzer(®) Cardiac Plug (St. Jude Medical Inc.) for the prevention of stroke in patients with atrial fibrillation is rapidly propagating. We sought to provide additional safety data. METHODS AND RESULTS: We have screened our database of patients having been treated with Amplatzer(®) Cardiac Plug and found 3 cases with uncommon complications that have not been reported previously. One patient experienced an embolisation of the occluder about 12 months after implantation that potentially resulted from mismatch of occluder size and landing zone. Another patient developed cardiac tamponade 9 days after implantation. This case of delayed effusion was probably not a result of interventional trauma, but might have been provoked by scratching of the inner pericardial membrane. A third patient developed a large thrombus in the left atrium which was considered to be caused by injury of the endothelial wall during implantation. The first two cases could be treated by a percutaneous procedure, the last case by cardiac surgery without any sequelae. CONCLUSIONS: Complications after left atrial appendage closure not related to a device-related thrombus can occur later after implantation. With appropriate percutaneous or surgical management these complications can be handled without sequelae.
Authors: Yat-Yin Lam; Gabriel W K Yip; Cheuk-Man Yu; Wilson W M Chan; Boron C W Cheng; Bryan P Yan; Richard Clugston; Gerald Yong; Tim Gattorna; Vincent Paul Journal: Catheter Cardiovasc Interv Date: 2011-11-30 Impact factor: 2.692
Authors: Jai-Wun Park; Armando Bethencourt; Horst Sievert; Gennaro Santoro; Bernhard Meier; Kevin Walsh; Jose Ramon Lopez-Minguez; Jose Ramon Lopez-Minquez; David Meerkin; Mariano Valdés; Oliver Ormerod; Boris Leithäuser Journal: Catheter Cardiovasc Interv Date: 2011-03-08 Impact factor: 2.692
Authors: Andreas Rillig; Boris Schmidt; Britta Feige; Erik Wissner; Andreas Metzner; Anita Arya; Shibu Mathew; Hisaki Makimoto; Peter Wohlmuth; Feifan Ouyang; Karl-Heinz Kuck; Roland Richard Tilz Journal: Clin Res Cardiol Date: 2013-07-30 Impact factor: 5.460
Authors: K R Julian Chun; Boris Schmidt; Karl-Heinz Kuck; Dietrich Andresen; Stefan Willems; Stefan G Spitzer; Ellen Hoffmann; Burghard Schumacher; Lars Eckardt; Karlheinz Seidl; Claus Jünger; Martin Horack; Johannes Brachmann; Jochen Senges Journal: Clin Res Cardiol Date: 2013-03-17 Impact factor: 5.460
Authors: David R Holmes; Vivek Y Reddy; Zoltan G Turi; Shephal K Doshi; Horst Sievert; Maurice Buchbinder; Christopher M Mullin; Peter Sick Journal: Lancet Date: 2009-08-15 Impact factor: 79.321
Authors: Enio Eduardo Guérios; Michael Schmid; Steffen Gloekler; Ahmed A Khattab; Peter M Wenaweser; Stephan Windecker; Bernhard Meier Journal: Arq Bras Cardiol Date: 2012-05-15 Impact factor: 2.000